Novel Superparamagnetic Iron Oxide Nanoparticles for Tumor Embolization Application: Preparation, Characterization and Double Targeting.

Xiaoli Chen,Haiyan Lv,Min Ye,Shengyu Wang,Erru Ni,Fanwei Zeng,Chang Cao,Fanghong Luo,Jianghua Yan
DOI: https://doi.org/10.1016/j.ijpharm.2012.01.043
IF: 6.51
2012-01-01
International Journal of Pharmaceutics
Abstract:The goal of this study was to develop novel embolic nanoparticles for targeted tumor therapy with dual targeting: magnetic field-guided and peptide-directed targeting. The embolic nanoparticles SP5.2/tTF-OCMCs-SPIO-NPs were prepared by surface-modifying of superparamagnetic iron oxide nanoparticles (SPIO-NPs) with o-carboxymethylchitosans (OCMCs) and SP5.2/tTF (SP5.2: a peptide binding to VEGFR-1; tTF: truncated tissue factor) to improve their stability and to target over-expressing VEGFR-1 cells. The physicochemical characterization results showed that the OCMCs-SPIO-NPs have a spherical or ellipsoidal morphology with an average diameter of 10–20nm. And they possess magnetism with a saturation magnetization of 66.1emu/g, negligible coercivity and remanence at room temperature. In addition, the confocal microscopy, Prussian blue staining and FX activation analysis respectively demonstrated the peptide-directed targeting, magnetic field-guided targeted and blood coagulation activity of the SP5.2/tTF-OCMCs-SPIO-NPs. These properties separately belong to SP5.2, Fe3O4 and tTF moieties of the SP5.2/tTF-OCMCs-SPIO-NPs. Thus these SP5.2/tTF-OCMCs-SPIO-NPs with double-targeting function should have a potential application in embolization therapy of tumor blood vessels.
What problem does this paper attempt to address?